Commentary on: Subgroup analysis and interpretation for phase 3 confirmatory trials: White Paper of the EFSPI/PSI working group on subgroup analysis by Dane, Spencer, Rosenkranz, Lipkovich, and Parke

Detalles Bibliográficos
Autores principales: Hemmings, Robert, Koch, Armin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593771/
https://www.ncbi.nlm.nih.gov/pubmed/30900391
http://dx.doi.org/10.1002/pst.1935
_version_ 1783430120646639616
author Hemmings, Robert
Koch, Armin
author_facet Hemmings, Robert
Koch, Armin
author_sort Hemmings, Robert
collection PubMed
description
format Online
Article
Text
id pubmed-6593771
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65937712019-07-10 Commentary on: Subgroup analysis and interpretation for phase 3 confirmatory trials: White Paper of the EFSPI/PSI working group on subgroup analysis by Dane, Spencer, Rosenkranz, Lipkovich, and Parke Hemmings, Robert Koch, Armin Pharm Stat Commentaries John Wiley and Sons Inc. 2019-03-21 2019 /pmc/articles/PMC6593771/ /pubmed/30900391 http://dx.doi.org/10.1002/pst.1935 Text en © 2019 The Authors Pharmaceutical Statistics Published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentaries
Hemmings, Robert
Koch, Armin
Commentary on: Subgroup analysis and interpretation for phase 3 confirmatory trials: White Paper of the EFSPI/PSI working group on subgroup analysis by Dane, Spencer, Rosenkranz, Lipkovich, and Parke
title Commentary on: Subgroup analysis and interpretation for phase 3 confirmatory trials: White Paper of the EFSPI/PSI working group on subgroup analysis by Dane, Spencer, Rosenkranz, Lipkovich, and Parke
title_full Commentary on: Subgroup analysis and interpretation for phase 3 confirmatory trials: White Paper of the EFSPI/PSI working group on subgroup analysis by Dane, Spencer, Rosenkranz, Lipkovich, and Parke
title_fullStr Commentary on: Subgroup analysis and interpretation for phase 3 confirmatory trials: White Paper of the EFSPI/PSI working group on subgroup analysis by Dane, Spencer, Rosenkranz, Lipkovich, and Parke
title_full_unstemmed Commentary on: Subgroup analysis and interpretation for phase 3 confirmatory trials: White Paper of the EFSPI/PSI working group on subgroup analysis by Dane, Spencer, Rosenkranz, Lipkovich, and Parke
title_short Commentary on: Subgroup analysis and interpretation for phase 3 confirmatory trials: White Paper of the EFSPI/PSI working group on subgroup analysis by Dane, Spencer, Rosenkranz, Lipkovich, and Parke
title_sort commentary on: subgroup analysis and interpretation for phase 3 confirmatory trials: white paper of the efspi/psi working group on subgroup analysis by dane, spencer, rosenkranz, lipkovich, and parke
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593771/
https://www.ncbi.nlm.nih.gov/pubmed/30900391
http://dx.doi.org/10.1002/pst.1935
work_keys_str_mv AT hemmingsrobert commentaryonsubgroupanalysisandinterpretationforphase3confirmatorytrialswhitepaperoftheefspipsiworkinggrouponsubgroupanalysisbydanespencerrosenkranzlipkovichandparke
AT kocharmin commentaryonsubgroupanalysisandinterpretationforphase3confirmatorytrialswhitepaperoftheefspipsiworkinggrouponsubgroupanalysisbydanespencerrosenkranzlipkovichandparke

Ejemplares similares